Pharmafile Logo
Pharmafocus logo
Advanced Search

pharma

Showing 15 posts of 2914 posts found.

astrazeneca-sign

AstraZeneca chalks up double Japanese approval in lung and breast cancer

July 2, 2018
Sales and Marketing AstraZeneca, Cancer, Imfinzi, NSCLD, breast cancer, lung cancer, lynparza, pharma

It’s a big step forward for AstraZeneca’s global marketing operations as the company announced that two of its products have …

News
takeda_usa_pharmaceuticals_u

Takeda’s Entyvio secures Japanese approval in ulcerative colitis

July 2, 2018
Sales and Marketing Entyvio, Japan, Takeda, pharma, ulcerative colitis

Takeda Pharmaceutical has announced that its monoclonal antibody, Entyvio (vedolizumab), has been approved for the treatment of patients with moderately …

News
abbvie_0

AbbVie ordered to pay $448m over generic delays

July 2, 2018
Sales and Marketing AbbVie, FTC, androgel, besins, branded generics, pharma

A US Judge has ordered pharmaceutical company AbbVie to pay $448 million after determining that the company had used sham …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 29, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HIV, J&J, JJ, Remicade, Roche, biosimilar Amgen, lung cancer, multiple sclerosis, pharma

Summer seems to be in full swing as we reach the end of June, so it’s time to look back …

News

Novartis spins off Alcon as CEO focuses drug search

June 29, 2018
Medical Communications, Sales and Marketing Alcon, Novartis, eye care, pharma

Novartis has announced a plan to spinoff Alcon – its eye care division – into a separately-traded standalone company.Novartis has …

News

Pfizer’s Xeljanz scores EU approval for active psoriatic arthritis

June 29, 2018
Medical Communications, Sales and Marketing EU, Europe, Pfizer, Xeljanz, pharma, psoriatic arthritis

Pfizer has announced that the European Commission (EC) has approved Xeljanz in combination with methotrexate (MTX) for the treatment of …

News

NICE turns down Roche’s Ocrevus in early primary progressive multiple sclerosis

June 29, 2018
Medical Communications, Sales and Marketing NICE, Ocrevus, Roche, pharma

Roche’s sometimes strained relationship with NICE continues as the health watchdog for England and Wales chose to reject the former’s …

News
amazon

Amazon makes first move into healthcare with online pharmacy acquisition

June 28, 2018
Medical Communications, Sales and Marketing amazon, pharma, pharmacy

It’s been thought to have been on the cards for some time, but now, after much speculation, retail giant Amazon …

News
baby-birth-born-161567

Ferring’s heat-stable drug could stop post-childbirth bleeding, WHO says

June 28, 2018
Research and Development Carbetocin, Ferring Pharmaceuticals, MSD, WHO, childbirth, pharma

A new formulation of a drug to prevent excessive bleeding in women after childbirth could save thousands of lives, says …

News
s_electronic_medical_record

Centralised EMR systems drive patient-physician relationships, report indicates

June 28, 2018
Medical Communications, Research and Development Electronic Medical Records, pharma

Advancement of IT within healthcare is transforming the dynamics of the patient-physician relationship and it is important to integrate various …

News
shutterstock_36423250

Summit Pharma axes Duchenne drug after Phase 2 failures

June 28, 2018
Research and Development Duchenne Muscular Dystrophy, Summit Pharmaceuticals, pharma, trial failure

Summit Therapeutics has revealed it is to terminate development of its Duchenne muscular dystrophy (DMD) drug ezutromid after it failed …

News

Roche’s Alecensa secures NICE approval in NSCLC after topping Pfizer’s Xalkori

June 28, 2018
Sales and Marketing Alecensa, NICE, NSCLC, Pfizer, Xalkori, pharma

UK health watchdog NICE has given its approval for Roche’s selective ALK inhibitor Alecensa (alectinib) for use on the NHS, …

News
amgen_hq

Amgen biosimilar proves non-inferior to J&J’s Remicade in rheumatoid arthritis

June 27, 2018
Research and Development, Sales and Marketing Amgen, Johnson & Jonson, Remicade, pharma, rheumatoid arthritis

Amgen has unveiled new Phase 3 data for its biosimilar version of Johnson & Johnson’s Remicade (infliximab), confirming that it …

News
shutterstock_95714119

US hospital’s ketamine study forced to a halt over consent concerns

June 27, 2018
Research and Development Hennepin Healthcare, Ketamine, pharma

Minneapolis-based hospital Hennepin County Medical Center has put the brakes on a clinical trial investigating the efficacy of ketamine in …

News
abbvie_0

Abbvie and Google’s Calico extend age-related disease partnership to $2.5bn

June 27, 2018
Research and Development, Sales and Marketing AbbVie, Cancer, Goggle, calico, pharma

The partnership of Abbvie and Google’s Calico has announced they are to extend their existing 10-year drug discovery and development …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026